{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-11-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "Y",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "NIA",
      "openfda": {
        "registration_number": [
          "2032682",
          "3004530258",
          "3016838963"
        ],
        "fei_number": [
          "3004530258",
          "3016838963",
          "3003952975"
        ]
      },
      "review_panel": "MI",
      "medical_specialty": "MI",
      "device_name": "Assay, Direct, Nucleic Acid Amplification, Influenza Virus",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Microbiology",
      "device_class": "1",
      "definition": "These reagents are nucleic acid primers and probes for the amplification and identification of Influenza virus directly from clinical specimens.  The identification aids in the diagnosis of influenza and provides epidemiological information on this disease.  This reagent differs from the description in the regulation in that it consists of nucleic acid primers and probes rather than antisera.",
      "regulation_number": "866.3330",
      "implant_flag": "N",
      "submission_type_id": "1"
    }
  ]
}